Serial Procalcitonin Predicts Mortality in Severe Sepsis Patients: Results From the Multicenter Procalcitonin MOnitoring SEpsis (MOSES) Study

Schüetz, Philipp; Birkhahn, Robert; Sherwin, Robert; E. Jones, Alan; J. Singer, Adam; A. Kline, Jeffrey; S. Runyon, Michael; H. Self, Wesley; Mark Courtney, D.; M. Nowak, Richard; F. Gaieski, David; Ebmeyer, Stefan; Johannes, Sascha; Wiemer, J.; Schwabe, Andrej; I. Shapiro, Nathan

doi:10.1097/ccm.0000000000002321

Public

Serial Procalcitonin Predicts Mortality in Severe Sepsis Patients: Results From the Multicenter Procalcitonin MOnitoring SEpsis (MOSES) Study

Published in Critical Care Medicine • Mar 3, 2017

Authors:

Philipp Schüetz

Robert Birkhahn

Robert Sherwin

Abstract

OBJECTIVES: To prospectively validate that the inability to decrease procalcitonin levels by more than 80% between baseline and day 4 is associated with increased 28-day all-cause mortality in a large sepsis patient population recruited across the United States. DESIGN: Blinded, prospective multicen...

Subject

Medicine

Procalcitonin

Sepsis

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!